Efficacy and Safety of Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review Incorporating an Indirect Comparisons Meta-Analysis

Background: The non-steroidal mineralocorticoid receptor antagonists (MRAs) are promising treatments in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). We conducted a meta-analysis to explore the efficacy and safety of the non-steroidal MRAs (finerenone, apararenone, esaxerenon...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xinrui Jiang, Zhengji Zhang, Chunlu Li, Shijin Zhang, Qiang Su, Siyun Yang, Xin Liu, Ying Hu, Xiaofeng Pu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-06-01
coleção:	Frontiers in Pharmacology
Assuntos:	finerenone apararenone esaxerenone mineralocorticoid receptor antagonists type 2 diabetes chronic kidney disease
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2022.896947/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!